Brief: Clinuvel Pharmaceuticals Posts HY Net Profit After Tax A$10.4 Million
26/02/2026 01:23
Feb 26 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX: HY NET PROFIT AFTER TAX A$10.4 MILLION HY REVENUES A$36.9 MILLION Further company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist